The economics of deep and machine learning-based algorithms for COVID-19 prediction, detection, and diagnosis shaping the organizational management of hospitals

George Lăzăroiu, Tom Gedeon, Elżbieta Rogalska, Mihai Andronie, Katarína Frajtová Michalíková, Zdenka Musová, Mariana Iatagan, Cristian Uţă, Lucia Michalkova, Mária Kováčová, Roxana Ștefănescu, Iulian Hurloiu, Stanislav Zábojník, Róbert Štefko, Adrian Dijmărescu, Irina Dijmărescu, Marinela GeamănuOeconomia 2024 · DOI

TL;DR

This paper reviews how deep and machine learning (ML) algorithms are revolutionizing COVID-19 management by improving prediction, detection, and diagnosis. It highlights their crucial role in optimizing hospital operations, resource allocation, and patient outcomes, ultimately aiming to mitigate the immense financial and operational strain on healthcare systems.

What Problem Does This Paper Address?

The COVID-19 pandemic placed unprecedented financial and operational stress on hospitals worldwide. This paper addresses the challenge of managing this crisis effectively by exploring how advanced computational tools, specifically deep and machine learning algorithms, can enhance various aspects of hospital management. These include predicting disease spread, accurately diagnosing infections, optimizing patient care pathways, and improving resource allocation. The authors aim to demonstrate how these technologies can lead to better patient survival rates, reduced medical errors, and a more efficient, less financially burdensome healthcare system, especially in the face of overwhelming demand and complex clinical scenarios.

Methods

This paper is a comprehensive review of existing literature. The authors employed a systematic methodology for article screening and quality evaluation, utilizing a suite of established software systems: AMSTAR, AXIS, DistillerSR, Eppi-Reviewer, MMAT, PICO Portal, Rayyan, ROBIS, and SRDR. This approach ensures a thorough and reliable synthesis of research findings on the application of deep and machine learning in COVID-19 management. The paper itself does not introduce new algorithms but rather analyzes and categorizes the applications of various ML and deep learning techniques as reported in the literature.

Datasets

Not discussed in the paper. The paper is a literature review and does not present its own experimental results or introduce new datasets.

Key Insights and Ideas

  • ML as a Multifaceted Solution: Deep and machine learning are not just for prediction; they are being applied across the entire patient journey, from initial screening and diagnosis to treatment optimization, resource allocation, and even forecasting mortality.
  • Data is King: The effectiveness of these algorithms hinges on the availability and quality of diverse data sources, including clinical signs, surveillance data, laboratory biomarkers, medical images (X-rays, CT scans), patient demographics, and even real-time symptom data.
  • Economic Impact is Significant: While these technologies promise efficiency, the paper acknowledges the substantial financial implications. Increased use of PPE, medication, and staff, alongside potential revenue losses from cancelled procedures, creates a complex economic landscape that ML can help navigate by optimizing resource use and predicting demand.
  • Beyond Diagnosis: The focus extends beyond simply identifying COVID-19. ML is crucial for predicting disease severity, patient prognosis, and identifying high-risk individuals, enabling proactive and personalized care.
  • Hospital Operations Optimization: ML algorithms are proving invaluable for optimizing ICU bed allocation, triaging patients, and improving overall hospital workflow, thereby reducing operational bottlenecks and enhancing care delivery.

Key Results

As this is a review paper, it synthesizes findings from numerous studies rather than presenting single quantitative results. The key "results" are the broad applications and demonstrated benefits of ML and deep learning across various facets of COVID-19 management:

  • Improved Prediction: Algorithms can forecast COVID-19 spread, confirmed cases, and mortality rates with increasing accuracy.
  • Enhanced Diagnosis: ML aids in image-based diagnosis (e.g., X-rays, CT scans) and symptom analysis, leading to earlier and more accurate detection.
  • Optimized Treatment: Personalized treatment strategies and supportive measures are being developed based on ML-driven predictions of patient outcomes and risk factors.
  • Efficient Resource Allocation: Algorithms help in optimizing ICU bed allocation, medical supply management, and staffing, crucial for handling surges in patient volume.
  • Reduced Medical Errors: By providing data-driven insights, ML can assist clinicians in decision-making, potentially reducing errors and improving patient safety.
  • Financial Management: ML tools can help hospitals forecast demand, manage costs associated with increased care needs, and mitigate financial vulnerabilities.

Limitations and Future Work

  • Data Dependency: The performance of ML models is heavily reliant on the quality, quantity, and representativeness of the data used for training. Biased or incomplete data can lead to inaccurate predictions.
  • Interpretability: While powerful, some deep learning models can be "black boxes," making it challenging to understand the reasoning behind their predictions, which can be a barrier to clinical adoption.
  • Generalizability: Models trained on data from one region or hospital may not perform as well in different settings due to variations in patient populations, healthcare practices, and data collection methods.
  • Ethical Considerations: The use of AI in healthcare raises ethical questions regarding data privacy, algorithmic bias, and accountability.

The authors implicitly suggest future work by highlighting the ongoing development and application of these algorithms. Future research will likely focus on improving model interpretability, ensuring fairness and equity in AI-driven healthcare, developing more robust and generalizable models, and integrating these tools seamlessly into clinical workflows to maximize their impact on patient care and healthcare economics.

Summary updated

Abstract

Research background: Deep and machine learning-based algorithms can assist in COVID-19 image-based medical diagnosis and symptom tracing, optimize intensive care unit admission, and use clinical data to determine patient prioritization and mortality risk, being pivotal in qualitative care provision, reducing medical errors, and increasing patient survival rates, thus diminishing the massive healthcare system burden in relation to severe COVID-19 inpatient stay duration, while increasing operational costs throughout the organizational management of hospitals. Data-driven financial and scenario-based contingency planning, predictive modelling tools, and risk pooling mechanisms should be deployed for additional medical equipment and unforeseen healthcare demand expenses. Purpose of the article: We show that deep and machine learning-based and clinical decision making systems can optimize patient survival likelihood and treatment outcomes with regard to susceptible, infected, and recovered individuals, performing accurate analyses by data modeling based on vital and clinical signs, surveillance data, and infection-related biomarkers, and furthering hospital facility optimization in terms of intensive care unit bed allocation. Methods: The review software systems employed for article screening and quality evaluation were: AMSTAR, AXIS, DistillerSR, Eppi-Reviewer, MMAT, PICO Portal, Rayyan, ROBIS, and SRDR. Findings & value added: Deep and machine learning-based clinical decision support tools can forecast COVID-19 spread, confirmed cases, and infection and mortality rates for data-driven appropriate treatment and resource allocations in effective therapeutic and diagnosis protocol development, by determining suitable measures and regulations and by using symptoms and comorbidities, vital signs, clinical and laboratory data and medical records across intensive care units, impacting the healthcare financing infrastructure. As a result of heightened use of personal protective equipment, hospital pharmacy and medication, outpatient treatment, and medical supplies, revenue loss and financial vulnerability occur, also due to expenses related to hiring additional staff and to critical resource expenditures. Hospital costs for COVID-19 medical care, screening, treatment capacity expansion, and personal protective equipment can lead to further financial losses while affecting COVID-19 frontline hospital workers and patients.
BibTeX
@inproceedings{lazaroiu2024economics,
  author = {George Lăzăroiu and Tom Gedeon and Elżbieta Rogalska and Mihai Andronie and Katarína Frajtová Michalíková and Zdenka Musová and Mariana Iatagan and Cristian Uţă and Lucia Michalkova and Mária Kováčová and Roxana Ștefănescu and Iulian Hurloiu and Stanislav Zábojník and Róbert Štefko and Adrian Dijmărescu and Irina Dijmărescu and Marinela Geamănu},
  title = {{The economics of deep and machine learning-based algorithms for COVID-19 prediction, detection, and diagnosis shaping the organizational management of hospitals}},
  booktitle = {Oeconomia},
  year = {2024},
  doi = {10.24136/oc.2984},
}
Figure